‌

US Patent 10597435 Insulin-Fc fusions and methods of use

Patent 10597435 was granted and assigned to Akston Biosciences Corporation on March, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Akston Biosciences Corporation

0

Current Assignee

Akston Biosciences Corporation

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

March 24, 2020

0

Patent Application Number

164386810

Date Filed

June 12, 2019

0

Patent Citations Received

US Patent 11919935 Ultra-long acting insulin-Fc fusion proteins and methods of use

0

US Patent 11773151 Ultra-long acting insulin-Fc fusion proteins and methods of use

US Patent 11352407 Ultra-long acting insulin-Fc fusion proteins

US Patent 11359001 Insulin-Fc fusions and methods of use

US Patent 11555058 Cells engineered to express ultra-long acting insulin-Fc fusion proteins

US Patent 11261229 Ultra-long acting insulin-Fc fusion proteins and methods of use

US Patent 11267862 Ultra-long acting insulin-Fc fusion proteins and methods of use

US Patent 11667689 Insulin-Fc fusion proteins and methods of use to treat cancer

0

...

Patent Primary Examiner

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10597435 Insulin-Fc fusions and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.